About usOur teamOur pipelineContact us

Investors

annual reportS

September 2022

RAD Annual Report June 2022

Download
September 2022

RAD ESG Report 2022

Download

shareholder newsletter

May 2023

Radiopharm Newsletter 1st Quarter 2023

Download
December 2022

Radiopharm Newsletter December 2022

Download
July 2022

Radiopharm Newsletter July 2022

Download
March 2022

Radiopharm Newsletter March 2022 - Meet our CEO in Australia

Download

ANalyst coverage

June 2023

Diamond Equity Research Update 5 June 2023

Download
June 2023

Bell Potter Research update Valuation at 25 cents per share 1 Jun 2023

Download
April 2023

Jones Research - Initiation of Coverage Price Target 75 cents per share

Download
March 2023

Bell Potter Initiation of Coverage - Going After Cancer

Download

corporate governance

Radiopharm Theranostics Prospectus and Supplementary Disclaimers

Download

Radiopharm Theranostics Prospectus

Download

Radiopharm Theranostics Supplementary Prospectus

Download

Corporate Governance

Download

corporate policies

Privacy Policy

Download

Sign up to our mailing list.

Receive all the latest news from Radiopharm Theranostics.